Fig. 6From: Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritisMean change from baseline in ES in the non-DMARD-IR population. Data are as observed in individual studies and estimated with meta-analysis. Solid line represents the mean estimate for a given treatment arm and the dashed lines show the corresponding 95Â % credible interval. DMARD: disease-modifying anti-rheumatic drugs; DMARD-IR: patient population with moderate-to-severe rheumatoid arthritis with a history of inadequate response to DMARDs who are currently treated with one (other) non-biologic DMARD; ES: Erosion Subscore; LEF: leflunomide; MTX: methotrexate; SSZ: sulfasalazineBack to article page